We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.4%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.9M |
| 2 |
AutoZone
AZO
|
+$61.2M |
| 3 |
Hershey
HSY
|
+$46.1M |
| 4 |
Intercontinental Exchange
ICE
|
+$41.2M |
| 5 |
General Motors
GM
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$104M |
| 2 |
Biogen
BIIB
|
+$89.3M |
| 3 |
Coca-Cola
KO
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$59.1M |
| 5 |
American Homes 4 Rent
AMH
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECOM
526
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.13M | 0.02% |
134,316
-17,478
| -12% | -$202K |
|
527
Ultragenyx Pharmaceutical
RARE
$2.56B
| $2.1M | 0.02% |
26,806
+17,029
| +174% | +$1.13M |
|
528
Plains GP Holdings
PAGP
$5.2B
| $2.06M | 0.02% |
232,010
+12,456
| +6% | +$110K |
|
529
HUB Group
HUBG
$2.92B
| $2.04M | 0.02% |
85,290
-4,908
| -5% | -$113K |
|
530
Cerence
CRNC
$368M
| $2.04M | 0.02% |
49,884
+35,161
| +239% | +$1.01M |
|
|
CCRN
531
DELISTED
Cross Country Healthcare
CCRN
| $2.02M | 0.02% |
328,315
+26,148
| +9% | +$160K |
|
532
Coherus Oncology
CHRS
$222M
| $2M | 0.02% |
112,085
-43,641
| -28% | -$739K |
|
533
Corpay
CPAY
$25.1B
| $2M | 0.02% |
+7,934
| New | +$1.88M |
|
|
ESPR
534
DELISTED
Esperion Therapeutics
ESPR
| $1.98M | 0.02% |
38,620
+461
| +1% | +$19.3K |
|
|
535
Coca-Cola
KO
$380B
| $1.98M | 0.02% |
44,203
-1,439,521
| -97% | -$66.3M |
|
|
TUP
536
DELISTED
Tupperware Brands Corporation
TUP
| $1.97M | 0.02% |
414,426
+316,594
| +324% | +$1.05M |
|
537
CEVA Inc
CEVA
$883M
| $1.97M | 0.02% |
52,503
| – | – |
|
|
LCI
538
DELISTED
Lannett Company, Inc.
LCI
| $1.96M | 0.02% |
67,453
+22,849
| +51% | +$710K |
|
539
Selective Insurance
SIGI
$5.63B
| $1.96M | 0.02% |
37,108
+22,098
| +147% | +$1.12M |
|
|
HTBK
540
DELISTED
Heritage Commerce
HTBK
| $1.96M | 0.02% |
260,594
+143,850
| +123% | +$1.13M |
|
|
TRST
541
Trustco Bank Corp NY
TRST
$984M
| $1.91M | 0.02% |
60,253
+25,370
| +73% | +$750K |
|
|
ACBI
542
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.91M | 0.02% |
156,820
+661
| +0.4% | +$7.59K |
|
543
Alpha and Omega Semiconductor
AOSL
$863M
| $1.9M | 0.02% |
174,702
+17,222
| +11% | +$176K |
|
544
Metallus
MTUS
$879M
| $1.9M | 0.02% |
487,267
+91,860
| +23% | +$307K |
|
|
PRAH
545
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.89M | 0.02% |
19,380
-20,429
| -51% | -$1.9M |
|
546
Atara Biotherapeutics
ATRA
$70.4M
| $1.87M | 0.02% |
5,132
+4,638
| +939% | +$1.17M |
|
|
DRNA
547
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.87M | 0.02% |
+73,572
| New | +$1.58M |
|
|
WWE
548
DELISTED
World Wrestling Entertainment
WWE
| $1.87M | 0.02% |
+42,949
| New | +$1.84M |
|
549
Granite Construction
GVA
$5.31B
| $1.79M | 0.02% |
93,684
| – | – |
|
550
CME Group
CME
$93.5B
| $1.78M | 0.02% |
+10,954
| New | +$1.96M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2020 Portfolio in Review
As of Q2 2020, Jacobs Levy Equity Management held 1,206 positions worth $9.23B, up 19% from $7.78B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jacobs Levy Equity Management's Q2 2020 filing shows 212 new, 430 increased, 347 reduced and 177 closed positions. Its largest new stake was Lowe's Companies: 259,943 shares worth $35.1M. The largest sale was Mastercard, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q2 2020 buy was Lowe's Companies: 259,943 shares worth $35.1M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2020, an estimated $62.9M increase.
- Jacobs Levy Equity Management's biggest Q2 2020 reduction was Mastercard, cutting an estimated $104M.
- Jacobs Levy Equity Management fully exited Sysco in Q2 2020, selling an estimated $36.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 19% of its $9.23B portfolio in Q2 2020.
- Jacobs Levy Equity Management opened 212 new positions and closed 177 in Q2 2020.
- Jacobs Levy Equity Management's portfolio value rose 19% quarter-over-quarter to $9.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.